Antissp. z o.o.

General medical practice activities

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2016-03-16
Share capital
5,000.00 PLN
Registered address
ul. Juliusza Słowackiego 18/2, 40-093 Katowice, Poland
Electronic delivery address
AE:PL-24620-67578-UCCUA-29

Financials

Revenue history (in k)

Filing timeliness

1 of 6 financial statements was filed late (for 2021, 94 days late).

  • 202510/07/2026
  • 202425/06/2025
  • 202308/07/2024
  • 202205/07/2023
  • 202117/10/2022
  • 202004/10/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Industry · General medical practice activities1,817 / 2,019
Top 90%
Division · Human health activities5,259 / 6,274
Top 84%
Top 83%
City · Katowice3,837 / 6,171
Top 62%
Voivodeship · Śląskie21,818 / 33,281
Top 66%
Country · Poland194,152 / 297,932
Top 65%

Results vs industry

Revenue
This companyUSD 102.42kMedianUSD 766.10kAverageUSD 2.40m
Net profit
This companyUSD 33.30kMedianUSD 38.62kAverageUSD 163.20k
Operating costs
This companyUSD 64.06kMedianUSD 680.10kAverageUSD 2.18m
Assets
This companyUSD 73.81kMedianUSD 261.25kAverageUSD 1.56m

Authorized Representatives

Barbara Jolanta Szywała – President of the Management Board

Manner of representation

In the case of a multi-member management board, each member of the management board independently is authorised to conduct the affairs of the company and represent it.

Ownership

OwnerSharesShare valueStake
Renata Marta Kaczmarczykage 90
96$1,296.6096%
Others
4$54.024%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2021-09-01.

No bank accounts reported to the VAT Taxpayer Register.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$55
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,282

FAQ

Last updated: 2026-07-23